U
Biofrontera AG
BFFTF
$1.08
-$0.27-20.00%
D
Sell
11/9/2021Upgraded
Biofrontera AG (BFFTF) was upgraded to D from E+ on 11/09/2021.
Biofrontera AG (BFFTF) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Biofrontera AG (BFFTF) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index.
Biofrontera AG (BFFTF) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index.
D
Sell
8/20/2021Upgraded
Biofrontera AG (BFFTF) was upgraded to D from D- on 8/20/2021 due to a substantial increase in the growth index, solvency index and volatility index. Total revenue increased 39.01% from $6.6M to $9.18M, EBIT increased 24.1% from -$4.93M to -$3.74M, and earnings per share increased from -$0.1085 to -$0.0849.
Biofrontera AG (BFFTF) was upgraded to D from D- on 8/20/2021 due to a substantial increase in the growth index, solvency index and volatility index. Total revenue increased 39.01% from $6.6M to $9.18M, EBIT increased 24.1% from -$4.93M to -$3.74M, and earnings per share increased from -$0.1085 to -$0.0849.
D
Sell
5/22/2020Downgrade
Biofrontera AG (BFFTF) was downgraded to D- from D on 5/22/2020 due to a large decline in the efficiency index, growth index and solvency index. Debt to equity increased from 2.02 to 5.44, EBIT declined 99.03% from -$2.53M to -$5.04M, and earnings per share declined from -$0.1038 to -$0.1544.
Biofrontera AG (BFFTF) was downgraded to D- from D on 5/22/2020 due to a large decline in the efficiency index, growth index and solvency index. Debt to equity increased from 2.02 to 5.44, EBIT declined 99.03% from -$2.53M to -$5.04M, and earnings per share declined from -$0.1038 to -$0.1544.
D
Sell
4/8/2020Upgraded
Biofrontera AG (BFFTF) was upgraded to D from D- on 4/8/2020 due to an increase in the volatility index, total return index and valuation index.
Biofrontera AG (BFFTF) was upgraded to D from D- on 4/8/2020 due to an increase in the volatility index, total return index and valuation index.
D
Sell
3/24/2020Downgrade
Biofrontera AG (BFFTF) was downgraded to D- from D on 3/24/2020 due to a large decline in the volatility index, total return index and efficiency index.
Biofrontera AG (BFFTF) was downgraded to D- from D on 3/24/2020 due to a large decline in the volatility index, total return index and efficiency index.
D
Sell
11/25/2019Downgrade
Biofrontera AG (BFFTF) was downgraded to D from D+ on 11/25/2019 due to a significant decline in the valuation index, efficiency index and solvency index. Net income declined 198.22% from $13.08M to -$12.85M, debt to equity increased from 0.76 to 1.38, and total capital declined 26.74% from $54.44M to $39.89M.
Biofrontera AG (BFFTF) was downgraded to D from D+ on 11/25/2019 due to a significant decline in the valuation index, efficiency index and solvency index. Net income declined 198.22% from $13.08M to -$12.85M, debt to equity increased from 0.76 to 1.38, and total capital declined 26.74% from $54.44M to $39.89M.
D
Sell
11/20/2019Downgrade
Biofrontera AG (BFFTF) was downgraded to D+ from C- on 11/20/2019 due to a decline in the volatility index and total return index.
Biofrontera AG (BFFTF) was downgraded to D+ from C- on 11/20/2019 due to a decline in the volatility index and total return index.
C
Hold
11/5/2019Upgraded
Biofrontera AG (BFFTF) was upgraded to C- from D+ on 11/5/2019 due to a noticeable increase in the valuation index and solvency index.
Biofrontera AG (BFFTF) was upgraded to C- from D+ on 11/5/2019 due to a noticeable increase in the valuation index and solvency index.
D
Sell
8/28/2019Upgraded
Biofrontera AG (BFFTF) was upgraded to D+ from D on 8/28/2019 due to a substantial increase in the efficiency index, valuation index and volatility index. Net income increased 536.56% from -$3M to $13.08M, and total capital increased 39.99% from $38.89M to $54.44M.
Biofrontera AG (BFFTF) was upgraded to D+ from D on 8/28/2019 due to a substantial increase in the efficiency index, valuation index and volatility index. Net income increased 536.56% from -$3M to $13.08M, and total capital increased 39.99% from $38.89M to $54.44M.
D
Sell
5/1/2019Upgraded
Biofrontera AG (BFFTF) was upgraded to D from D- on 5/1/2019 due to an increase in the growth index and efficiency index. Net income increased 172.54% from -$5.32M to $3.86M, earnings per share increased from -$0.1214 to $0.0834, and operating cash flow increased 67.14% from -$5.75M to -$1.89M.
Biofrontera AG (BFFTF) was upgraded to D from D- on 5/1/2019 due to an increase in the growth index and efficiency index. Net income increased 172.54% from -$5.32M to $3.86M, earnings per share increased from -$0.1214 to $0.0834, and operating cash flow increased 67.14% from -$5.75M to -$1.89M.
D
Sell
10/1/2018Upgraded
Biofrontera AG (BFFTF) was upgraded to D- from E+ on 10/1/2018 due to an increase in the solvency index and growth index.
Biofrontera AG (BFFTF) was upgraded to D- from E+ on 10/1/2018 due to an increase in the solvency index and growth index.
E
Sell
7/2/2018Upgraded
Biofrontera AG (BFFTF) was upgraded to E+ from E on 7/2/2018 due to a large increase in the total return index, solvency index and growth index. The quick ratio increased from 3.07 to 8.77, debt to equity declined from 3.63 to 0.59, and total revenue increased 4.06% from $5.52M to $5.75M.
Biofrontera AG (BFFTF) was upgraded to E+ from E on 7/2/2018 due to a large increase in the total return index, solvency index and growth index. The quick ratio increased from 3.07 to 8.77, debt to equity declined from 3.63 to 0.59, and total revenue increased 4.06% from $5.52M to $5.75M.
E
Sell
4/4/2018None
Biofrontera AG (BFFTF) was downgraded to E from U on 04/04/2018.
Biofrontera AG (BFFTF) was downgraded to E from U on 04/04/2018.
OTC PK
05/30/2023 10:45AM Eastern
Quotes delayed
